Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
09 Jun 2022 06:31 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS - Notice of Increase in Share Capital | 20103010 Biotechnology | Total number of voting rights and capital |
08 Jun 2022 12:12 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS announces appointment of Anders Wold as Chair of the Board | 20103010 Biotechnology | Non-regulatory press releases |
08 Jun 2022 11:58 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS: Minutes of Annual General Meeting 2022 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
01 Jun 2022 12:41 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS to present at the Annual International Symposium for Therapeutic Ultrasound (ISTU) Conference in Toronto | 20103010 Biotechnology | Non-regulatory press releases |
30 May 2022 15:45 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS - Notice of Annual General Meeting 2022 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
19 May 2022 14:30 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS Board Update | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
13 May 2022 13:30 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS announces start date of 6 June 2022 for its new Chief Executive Officer Per Walday, relocation of some activities to Oslo and Dominic Moreland stepping down as Chief Financial Officer | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
27 Apr 2022 21:11 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS announces the publication of its 2021 Annual Report | 20103010 Biotechnology | Annual financial and audit Reports |
28 Mar 2022 14:57 CEST |
EXACT THERAPEUTICS | EXACT Therapeutics AS Announces Appointment of Dr Per Walday as Chief Executive Officer | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
08 Mar 2022 23:03 CET |
EXACT THERAPEUTICS | Exact Therapeutics Announces Clinical Trial Update | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
24 Dec 2021 10:35 CET |
EXACT THERAPEUTICS | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
24 Dec 2021 10:35 CET |
EXACT THERAPEUTICS | Finansiell kalender | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
22 Dec 2021 14:22 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS Announces Allowance of Patent Application in Europe for Acoustic Cluster Therapy (ACT®) | 20103010 Biotechnology | Non-regulatory press releases |
21 Dec 2021 08:00 CET |
EXACT THERAPEUTICS | EXACT Therapeutics AS Awarded NOK 7.4 M Grant for the Development of its Next Generation Ultrasound Transducer and Navigation System for ACT® | 20103010 Biotechnology | Non-regulatory press releases |
13 Dec 2021 08:06 CET |
EXACT THERAPEUTICS | Exact Therapeutics AS to present at DNB Nordic Healthcare Conference on 16th December 2021 | 20103010 Biotechnology | Non-regulatory press releases |
13 Dec 2021 08:00 CET |
EXACT THERAPEUTICS | Exact Therapeutics AS to present at DNB Nordic Healthcare Conference on 16th December 2021 | 20103010 Biotechnology | Non-regulatory press releases |
06 Dec 2021 07:00 CET |
EXACT THERAPEUTICS | Exact Therapeutics AS Appoints Prominent Ultrasound And Healthcare Expert To Its Board Of Directors | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
05 Dec 2021 15:33 CET |
EXACT THERAPEUTICS | EXACT THERAPEUTICS AS - MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
03 Dec 2021 17:54 CET |
EXACT THERAPEUTICS | EXACT THERAPEUTICS AS – PROTOKOLL FRA EKSTRAORDINÆR GENERALFORSAMLING – VALG AV NYTT STYREMEDLEM | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
03 Dec 2021 17:53 CET |
EXACT THERAPEUTICS | Exact Therapeutics AS Minutes From Extraordinary General Meeting – Appointment Of New Board Member | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
25 Nov 2021 21:27 CET |
EXACT THERAPEUTICS | To the shareholders of EXACT Therapeutics AS - NOTICE OF EXTRAORDINARY GENERAL MEETING | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
25 Nov 2021 21:25 CET |
EXACT THERAPEUTICS | Til aksjonærene i EXACT Therapeutics AS - INNKALLING TIL EKSTRAORDINÆR GENERALFORSAMLING | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
25 Nov 2021 18:00 CET |
EXACT THERAPEUTICS | Til aksjonærene i EXACT Therapeutics AS - INNKALLING TIL EKSTRAORDINÆR GENERALFORSAMLING | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
25 Nov 2021 18:00 CET |
EXACT THERAPEUTICS | To the shareholders of EXACT Therapeutics AS - NOTICE OF EXTRAORDINARY GENERAL MEETING | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |